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The  once widely held  notion  that  acute allograft rejection is  mediated by 
cytolytic T  lymphocytes (CTL) (1, 2) 1 recently has been called into question (3). 
In the mouse, Loveland and colleagues (4, 5) demonstrated by adoptive transfer 
that T  lymphocyte subsets enriched for Lyt-l+,2  -  cells, and therefore thought 
to lack CTL precursors, were as effective in restoring allograft immunity as were 
unseparated T  lymphocytes. In  the rat,  Dallman  et al.  (6)  demonstrated that 
subsets  enriched  for  T  helper  lymphocytes (OX8-,  W3/25 ÷)  could  restore 
allograft immunity, but subsets enriched for CTL (OX8 +, W3/25-) could not. 
The simplest interpretation of these observations is that CTL are neither neces- 
sary nor sufficient for allograft rejection. However, several considerations suggest 
that  such  an  interpretation  may be  invalid.  First,  Dallman  et  al.  (6)  found 
significant numbers of OX8 + cells in rejecting allografts of recipients reconsti- 
tuted only with OX8- lymphocytes. As noted by the investigators, the presence 
of the OX8 + must be adequately explained before ruling out CTL as important 
effector cells in allograft rejection. Second, it is questionable whether adoptive 
transfer of the CTL subset, which is also likely to include T  suppressor lympho- 
cytes, is a fair evaluation of CTL function in allograft rejection since regulatory 
forces may be strongly shifted in  favor of nonreactivity. Finally, but perhaps 
most importantly, the prediction of T  lymphocyte function on the basis of cell 
surface differentiation antigens appears  to  be  more complex than  previously 
supposed (7-9). For example, unlike "typical" Lyt-l-,2  + CTL, some mouse CTL 
reactive with class II'histocompatibility antigens express the Lyt-l+,2  - phenotype 
(8).  This  could be particularly important  in  allograft rejection where a  CTL 
response to class II antigens of donor vascular-endothelial cells may represent a 
critical determinant of the rejection process (10-12).  Hence, it seems doubtful 
that any rigid conclusions concerning the relevance of CTL to allograft rejection 
can be deduced from the study of adoptively transferred lymphocytes that have 
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been selected solely on the basis of cell surface differentiation antigens. In order 
to avoid such ambiguities,  we studied the capacity of well-defined cloned CTL 
to  mediate  destruction  of allogeneic  tissue  in  vivo  in  terms  of immunologic 
specificity, dose  dependence,  host  cell  recruitment,  and  the  histologic  events 
associated  with in  vivo reactions.  Some of our findings have been reported in 
preliminary form (13). 
Materials and Methods 
Derivation of CTL  Clones and Subclones.  The derivation and characterization of the 
parental CTL clone 21-4 from C3H]He mice immunized with CBA]J  epidermal cells 
(EC) and its propagation with interleukin 2 (IL-2) and alloantigen has been described (14). 
The 21-4 CTL clone recognizes a tissue-restricted non-H-2 alloantigen of EC designated 
Epa-1 and is restricted by H-2K  k products (14). Four subclones of 21-4 (21-4.24, 21-4.29, 
21-4.33, and 21-4.85) were derived by micromanipulation of individual cells (15). In brief, 
1 ×  104 21-4 CTL were placed in a 60-ram dish containing 4 ml of IL-2 media and several 
fourfold dilutions were delivered into replicate dishes. The dishes were examined under 
an inverted phase contrast microscope to locate individual cells which then were removed 
with a fine-bore glass micropipette and transferred to a fresh dish containing media alone. 
The new dish was  examined to confirm the presence of a  single cell which was  then 
transferred to a  0.2-ml  microtiter well  containing  IL-2 and  "feeder cells"  (irradiated 
allogeneic CBA EC plus irradiated syngeneic spleen cells). After 1-2 wk of culture, the 
contents of wells with actively growing cells were transferred to 2-ml tissue culture wells 
containing IL-2 media and fresh feeder cells.  Cytolytic activity was  determined in  3-h 
51Cr-release assays, as previously described (14). 
Fluorescence-activated Cell Sorter (FACS) Analysis.  The CTL lines were propagated as 
described above and  then depleted of feeder cells  by Ficoll-diatrizoate sedimentation 
(LSM, Litton Bionetics, Kensington, MD). FACS analysis was conducted after staining the 
cells with monoclonal anti-mouse Lyt-1, Lyt-2, and Thy-I  Biotin-conjugated antibodies 
(nos.  1341,  135 I, and  1331, respectively; Becton Dickinson, Mountain View, CA) and 
with Biotin-conjugated monoclonal antibody 10-2.16 (anti-Ia. 17 obtained originally from 
Oi and Herzenberg, Stanford, CA and maintained locally by Dr. C. S. David) as a negative 
control. Cells were washed in phosphate-buffered saline (PBS) with 0.2% BSA and 0.05% 
NaN3  (PBS  buffer), aliquoted to 2  x  106 cells  per tube and incubated with  30 •g  of 
antibody-Biotin conjugate for 30 min on ice. After washing 3 times with PBS buffer, the 
supernatant fluids were discarded and the cells  were incubated with  30 #g of Avidin- 
FITC (no. BA-101, E-Y Labs, San Mateo, CA) in PBS buffer for 30 rain on ice. After 3 
more washes,  104 cells were analyzed with a Becton Dickinson FACS IV. 
Evaluation  of Cloned CTL Function In  Vivo.  The capacity of 21-4  CTL and its four 
subclones to mediate tissue destruction in vivo was determined using the immune lym- 
phocyte transfer tests (16). Cloned CTL were harvested from culture and feeder cells 
removed by Ficoll-diatrizoate sedimentation. Interface cells were collected and washed 4 
times in balanced salt solution containing 10% fetal calf serum (BSS/FCS) and the desired 
number of CTL (1-10 ×  106) were resuspended in 30 #1 of BSS/FCS. The CTL were 
injected intradermally with a  30-gauge needle on a  Hamilton syringe into the shaved 
lateral-thoracic region of the  test host and the  injection sites were observed daily for 
development of skin lesions.  Some mice were sacrificed at various intervals after injection 
and the skin and subcutis encompassing the injection site was excised and processed for 
1-#m thick, Epon-embedded, Giemsa-stained sections and transmission electron micros- 
copy as previously described (10). 
Results and Discussion 
We  first  injected  107  Epa-l-specific,  H-2Kk-restricted  clone  21-4  CTL  into 
syngeneic C3H control hosts or semiallogeneic (C3H × CBA)F~ hosts that express 236  CYTOLYTIC  T  LYMPHOCYTES  DESTROY  ALLOGENEIC  TISSUE 
FIGURE  1.  Gross appearance of the skin of a  (C3H  ×  CBA)F1 host (top) and a  syngeneic 
C3H/He host (bottom) 5 d after intradermal injection of 107 21-4 CTL. 
TABLE  I 
Spec~city  of Tissue Destruction by 21-4 CTL In Vivo 
No. with  H-2  No.  skin le-  Epa-10  K  I  D  Host*  tested  sions* 
(C3H × CBA)F~  29  29  +  k  k  k 
AKR  3  3  +  k  k  k 
B10.BR  5  5  +  k  k  k 
CBA  3  3  +  k  k  k 
RF  3  3  +  kk  k 
C3H/He  18  0  -  k  k  k 
B10.A  6  6  +  k  k/d  d 
BI0.OL  6  0  +  d  d  k 
BI0.MBR  6  0  +  b  k  q 
A/J  6  0  -  k  k/d  d 
C57BL/6  3  0  +  b  b  b 
* All hosts received 107 21-4 CTL intradermally. 
* Skin  lesions  in  susceptible hosts  invariably progressed to  ulceration 
within 5 d, whereas in nonsusceptible hosts no discernible lesions were 
observed at any time. 
Only one allelic form of Epa-1 has so far been defined; hence hosts are 
designated Epa- 1  ÷ or Epa- 1-. 
Epa-1 and H-2K  k. No discernible reaction was grossly apparent  in any syngeneic 
host  at  any  time,  whereas  every  FI  host  developed  a  progressive  skin  lesion 
characterized  by  edema  and  erythema  (day  1),  induration  (days  2-3),  and 
ulceration (days 3-5;  see  Fig.  1).  In more  than  45  tests,  we  never  have  experi- 
enced a  discrepancy from these observations (see Table  I). 
We  analyzed  the  pathogenesis  of  21-4  CTL-mediated  lesions  by  light  and 
electron  microscopy.  21-4  CTL  were  easily identified in  1-#m  sections  of skin 
reactions  by  virtue  of  their  prominent  cytoplasm  and  numerous  cytoplasmic 
granules  (Fig.  2,  a  and  c).  By  uitrastructure  (Fig.  2b),  21-4  CTL  cytoplasmic TYLER ET  AL.  237 
granules resembled those of other cloned mouse leukocytes that express natural 
killer  (NK)-like  activity  (17-19)  or  suppressor  (19)  or  cytolytic  (20)  T  cell 
function.  Like  cloned cells expressing  NK-lysis  or  suppressor T  cell  function 
(19),  21-4  CTL  also  exhibited  large  deposits  of cytoplasmic glycogen  when 
processed for electron microscopy by the osmium tetroxide-potassium ferrocya- 
nide technique (19). In (C3H x  CBA)F~ mice, injection of 21-4 CTL was followed 
by marked dermal edema, infiltration of dermis, and epidermis by 21-4  CTL, 
and necrosis of epidermal structures.  Hair  follicles were damaged particularly 
early and exhibited extensive necrosis by day 1 after injection (Fig. 2a). Necrosis 
involved large areas of the epidermis by day 2  (Fig.  2 c) and virtually the full- 
thickness of the dermis by day  3.  In addition to  21-4  CTL,  injection sites in 
(C3H  X  CBA)F1  hosts  also  exhibited  infiltration  by  host  leukocytes.  These 
included neutrophils, which were particularly prominent in and around necrotic 
structures (e.g. Fig. 2a and c), as well as occasional small mononuclear cells (e.g. 
Fig.  2c),  presumably representing  recruited  host  lymphocytes.  A  few  macro- 
phages,  identifiable  by  their  abundant  cytoplasm  with  large  phagolysosomes 
encompassing cellular and nuclear debris,  were present in the deep dermis in 
the vicinity of the initial injection site at day 2 and increased in number by day 
4. By contrast, light and electron microscopy revealed few, if any, macrophages 
in the upper dermis or epidermis. 
In contrast to susceptible (C3H x  CBA)F1 mice, C3H (control) hosts developed 
no cutaneous necrosis.  Instead,  21-4  CTL remained confined to the injection 
site (Fig. 2 d) where they were identifiable by light or electron microscopy for at 
least  4  d,  strongly  suggeting that  the  migration of 21-4  CTL  into epidermal 
structures is triggered by exposure to specific alloantigen (Epa-1). 
Having established that 21-4 CTL did evoke allogeneic tissue destruction in 
vivo, we next evaluated the immunologic specificity of the reaction by employing 
a  panel of hosts selected for various expression of Epa-1  and H-2 antigens. As 
shown in Table I, only hosts expressing both Epa-1 and H-2K k were susceptible 
to the destructive effects of 21-4 CTL. It should be noted that in many instances 
the nonsusceptible hosts were fully allogeneic to 21-4 CTL but no gross evidence 
of a host-vs.-clone response was observed at the injection site. The strain distri- 
bution of susceptible hosts exactly paralleled the susceptibility of host EC to lysis 
in  vitro  by  clone  21-4  CTL  (14).  Hence,  the  alloantigenic  (Epa-1)  and  H-2 
restriction (H-2K k) specificity of 21-4 CTL in vivo was identical to that recorded 
in vitro. 
We then analyzed the dose dependence of tissue destruction by 21-4 CTL. As 
shown in Table  II, all (C3H  x  CBA)FI  hosts receiving 5-10  x  108 21-4  CTL 
developed lesions within 3 d. By contrast, hosts receiving 2.5 x  106 had lesions 
by day 5, and only 1 of 3 hosts receiving 1 ×  106 CTL developed any ulceration. 
It should be noted that 21-4 CTL require an exogenous source of IL-2 for long- 
term  survival and  for  growth  in  response to alloantigen (14).  Therefore,  the 
minimum  number  of  21-4  CTL  required  for  consistent  lesion  formation  is 
probably less than 2.5 ×  106 cells because exogenous IL-2 was not provided in 
these experiments. 
We  next investigated whether radiosensitive host leukocytes were necessary 
participants in the development of the lesions, as would be expected if the lesions FIGURE 2.  Light and electron microscopic findings in skin injected with clone 21-4 CTL. (a) 
By day  1,  hair follicles (arrows) of Ft  mice exhibited necrosis and infiltration by clone 21-4 
CTL  and other leukocytes,  predominantly neutrophils. Clone  21-4  CTL  (solid arrowhead) 
were large, with an eccentrically located, often lobulated or reniform nucleus and prominent 
dark  cytoplasmic granules.  (b) Electron  micrograph  of a  typical clone 21-4 CTL  1 d  after 
injection into an FI mouse. Clone 21-4 CTL in control (C3H) injection sites or prepared for 
electron microscopy before their injection in vivo had a similar appearance by ultrastructure. 
Clone 21-4 CTL contain large, membrane-bound cytoplasmic granules, often distributed in 
greatest number on one side of the nucleus. The contents of some granules appear homoge- 
neously electron dense; others contain variable amounts of electron dense particles or small 
vesicular structures. N  =  nucleus.  (c) By day 9,  large regions of Fl  epidermis were necrotic 
(arrows)  and  infiltrated by  clone  21-4  CTL  (solid  arrowhead)  as  well  as  neutrophils and 
mononuclear cells apparently devoid of prominent cytoplasmic granules. In contrast to clone 
21-4 CTL,  dermal mast cells (open arrowhead) had a  less abundant cytoplasm with smaller 
and more numerous granules. (d)Control skin 3 d  after injection of clone 21-4 CTL,  which 
remained confined to the injection site (solid arrowheads) beneath the panniculus carnosus 
(PC). The dermis, epidermis, and hair follicles (open arrow-heads) appear normal. Scale bars: 
a, c, and d, 50 ~m. a, c, and d are 1 #m, Epon-embedded, Giemsa-stained sections. TYLER ET  AL.  239 
TABLE  II 
Dose Dependence of Tissue Destruction by 21-4 CTL 
Fraction with lesions* 
21-4 CTL cell  dose  Days postinjection 
1  2  3  4  5 
1 x  106  0/~  0/3  1/3  1/3  1/3 
2.5 x  106  0/3  1/3  2/3  2/3  3/3 
5 x  106  0/3  1/3  3/3  ~/3  3/3 
l0 x  106  0/~  0/3  3/3  3/3  3/3 
* A lesion was defined as ulceration at the site of injection. 
TABLE  III 
Radiosensitive Host Leukocytes Are Not Required  for Tissue Destruction 
by Cloned CTL 
No. with skin 
Host*  No. tested  lesions 
(C3H x CBA)F1  8  8 
C3H/He  4  0 
* Hosts were exposed to 850 rad of whole-body  x irradiation 24 h before 
intradermal injection of 107  21-4 CTL. All hosts died 7-15  d after 
irradiation. 
were  mediated by a  delayed-type hypersensitivity mechanism (21).  To address 
this possibility, (C3H  x  CBA)F1  hosts  were  lethally irradiated  (850  rads) and 
given an intradermal injection of 107  21-4  CTL 24 h  later. As shown in Table 
III, lethal irradiation of F~ hosts did not abrogate the capacity of 21-4  CTL to 
mediate tissue destruction.  In fact, the severity and tempo of the reactions in 
irradiated F~ hosts was somewhat increased. 
To provide further evidence that the in vivo reactions were unambiguously 
attributable  to CTL, we subcloned  21-4  CTL by micromanipulation of single 
cells.  Four  subclones  were  derived  and  all  proved  to  have  identical  in  vitro 
cytolytic specificity  as  21-4  CTL  (Table  IV).  When  tested  in  vivo,  all  four 
subclones (5 x  106 CTL per host) uniformly produced ulcerating lesions in (C3H 
×  CBA)F1 hosts (n =  3 for each subclone), whereas no lesions were produced in 
syngeneic C3H hosts (n =  3 for each subclone). 
We  investigated the  cell-surface phenotype of parental  and subcloned  21-4 
CTL by FACS analysis with monoclonal Thy-1, Lyt-1, and Lyt-2 antibodies. In 
three  such analyses, all  cells  of the parent and  subclones were  found to stain 
distinctly for Thy-1  and Lyt-2. However, as exemplified by the FACS plots in 
Fig. 3, on two of three occasions a small fraction of the cells (5-9%) of parental 
and subcloned 21-4 CTL also stained distinctly for Lyt-1. We have not elucidated 
the reason  for the  low variable  Lyt-1  expression,  but it  is  in accord with our 
previous results obtained with parental clone 21-4 CTL (14) as well as the recent 
results of Palladino et al. (22),  who detected low levels of Lyt-1 antigens on all 
the  Lyt-2  + CTL clones they examined.  Hence,  although the  majority of 21-4 
CTL express the typical Thy-1 +, Lyt-1-,2  + phenotype, a  more accurate descrip- 
tion of the cloned population is Thy-1 +, Lyt-1 +/-, 2 ÷ to reflect the variable Lyt- 240  CYTOLYTIC  T  LYMPHOCYTES  DESTROY  ALLOGENEIC  TISSUE 
TABLE  IV 
The Cytolytic Specificity of Clone 21-4 and Four of its Subclones 
In Vitro 
Clone or subclone 
Percent specific lysis of EC targets* 
CBA  B10.A  B10.OL  C3H 
21-4  76.4  23.8  -1.2  -0.7 
21-4.24  78.5  28.4  -1,9  -1.5 
21-4.29  71.9  25.9  -1,0  -0.8 
21-4.33  67.1  24.9  2.4  1.4 
21-4.85  64.1  31.3  -0.3  2.5 
* Percent  specific  lysis  was  determined  in  a  3-h  5~Cr-release  assay  as 
previously  described  (14).  Specific lysis  of all  spleen  cell  targets  was 
<6,3%  and  the  spontaneous  5~Cr release  was  always  <15.7%.  The 
effector-to-target  ratio  was  16:1.  For Epa-I and H-2 genotypes  of the 
target cell donors see Table I. 
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FIGURE 3.  FACS analysis of clones  21-4  and  21-4.29  (see  text  for  technical  details).  The 
histograms shown are typical of the results obtained on two of three occasions where reactivity 
with Lyt-1  monoclonal antibody was observed, as indicated by the small Lyt-1  peak. However, 
all the cells reacted with Lyt-2 and Thy-1 monoclonal antibodies on all three occasions. 
1 expression. 
The  results  of  the  present  study  prove  that  Lyt-2 ÷  CTL  are  capable  of 
mediating immunologically  specific destruction of allogeneic tissue in vivo in a 
dose-dependent  fashion.  Thus,  they support  the  findings of Engers et al.  (23) 
who  demonstrated  that  intravenous  injection  of cloned  Lyt-2 +,  H-2d-reactive 
CTL  induced  rejection  of P815  (H-2  d) tumor cells  in  the peritoneal  cavity  of 
immunosuppressed  hosts.  In  addition,  our  studies  extend  the  observations  of 
Enger et al. (23) by clearly demonstrating the in vivo immunologic specificity of 
the CTL and localizing their presence to the site of ailogeneic tissue destruction. 
For clarity of interpretation certain differences between our study and that of 
Engers et al. should be emphasized.  The Lyt-2 + CTL clones we used require an 
exogenous  source of IL-2  for proliferation  in  response  to alloantigen  in  vitro 
and presumably in vivo (14,  M. E. Snider and J. D. Tyler, unpublished observa- 
tions).  In contrast, the cloned Lyt-2 + CTL used by Engers et al.  are capable of 
producing  their  own  IL-2  and  it  was  speculated  that  this  property  may  be TYLER ET  AL.  241 
especially suitable to the in vivo function of cloned CTL.  II-2 was not provided 
in our experiments and it is improbable that  significant amounts of IL-2 were 
carried over from culture to in vivo sites in our studies because the CTL were 
thoroughly  washed  before  intradermal  injection.  Therefore,  it  would  appear 
that IL-2 is not essential for the effector function of Lyt-2  + CTL in vivo. On the 
other hand, if the intravenous route of injection is used, as in the study by Engers 
et al., a  source of IL-2 may be required to permit sufficient numbers of viable 
CTL to survive, migrate to, and effect destruction of allogeneic tissue at a distant 
site. 
The  precise  mechanism  by which  the cloned CTL  destroy allogeneic  tissue 
remains unknown,  but it would seem probable that direct cytolysis is involved. 
In addition, indirect mechanisms dependent on lymphokines produced by cloned 
CTL (23-25) or on blood vessel injury (26) may also play a role. In this regard, 
our  results  suggest  that  indirect  mechanisms,  if involved,  do  not  require  the 
participation of radiosensitive leukocytes. 
Our data taken  together with the frequent detection of alloimmune CTL in 
recipients of aIlografts and in allografts themselves (27-35) indicate that these T 
lymphocytes constitute an important barrier to successful transplantation.  How- 
ever, our results should not be construed as disputing a  role in transplantation 
immunity for other functionally distinct T  lymphocytes such as those mediating 
classic delayed-type hypersensitivity reactions (36-38).  In our view, the relative 
importance  and  precise contribution  of different effector mechanisms  may be 
addressed best by evaluating the efficacy of functionally distinct T  lymphocyte 
clones,  transferred  alone  or  in  combination,  to  mediate  rejection  of a  tissue 
allograft. 
Summary 
The  long-accepted  notion  that  alloimmune  cytolytic T  cells (CTL) mediate 
transplantation  immunity  has  recently  been  called  into  question.  In  order  to 
ascertain directly whether alloimmune CTL can mediate destruction of foreign 
tissue,  we tested the ability of mouse CTL expanded as cloned populations  in 
vitro  to  destroy  allogeneic  skin  in  vivo.  The  results  of these  studies  prove 
unequivocally that cloned Lyt-2  + CTL can perform this task in an immunologi- 
cally specific, H-2-restricted, and dose-dependent fashion. 
We thank N. Swanson, J. Newman, and J. Smith for technical assistance, Dr. C. S. David 
for  recombinant  inbred  mice,  D.  C.  Roopenian  for  assistance  in  micromanipulation 
subcloning,  Dr.  S.  Singh  for  FACS  analysis,  and  Shirley  Behnken  for  assistance  in 
manuscript preparation. 
Received  for publication 18July 1983 and in revised  form 29 September 1983. 
References 
1.  Miller, J. F. A. P., and D. Osoba. 1967. Current concepts of immunological  function 
of the thymus. Physiol. Rev. 47:437. 
2.  Cerottini,  J.-C.,  and  K.  T.  Brunner.  1974.  Cell-mediated  cytotoxicity,  allograft 
rejection and tumor immunity.  Adv. Immunol. 18:67. 
3.  Loveland, B. E., and I. F. C. McKenzie.  1982. Which T  cells cause graft rejection? 242  CYTOLYTIC T  LYMPHOCYTES  DESTROY  ALLOGENEIC  TISSUE 
Transplantation (Baltimore). 33:217. 
4.  Loveland, B. E.,  P. M.  Hogarth, R. H. Ceredig, and I. F. C. McKenzie.  1981. Cells 
mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J. 
Exp. Med. 153:1044. 
5.  Loveland, B. E., and I. F. C. McKenzie.  1982. Cells mediating graft rejection in the 
mouse. II. The Ly phenotype of cells producing tumor allograft rejection. Transplan- 
tation (Baltimore). 33:174. 
6.  Dallman, M.J., D. W. Mason, and M. Webb. 1982. The roles of host and donor cells 
in the rejection of skin allografts by T  cell deprived rats injected with syngeneic T 
cells. Eur. J. Immunol.  12:511. 
7.  Andrus, L., S. J. Prowse, and K. J. Lafferty. 1981. Interleukin 2 production by both 
Lyt-2  ÷ and Lyt-2- T  cell subsets. Scand. j. Immunol.  13:297. 
8.  Swain, S. L., G. Dennert, S. Wormsley, and R. W. Dutton.  1981. The Lyt phenotype 
of a  long term allospecific T  cell  line.  Both  helper and  killer activities to  Ia are 
mediated by Lyl cells. Eur.J. Immunol.  11:175. 
9.  Glasebrook, A. L., A. Kelsoe, and H. R. MacDonald.  1983. Cytolytic T  lymphocyte 
clones that proliferate autonomously to specific alloantigenic stimulation.  II. Rela- 
tionship of the Lyt-2 molecular complex to cytolytic activity proliferation and lym- 
phokine secretion. J. Immunol.  130:1545. 
10.  Dvorak, H., M.  C. Mihm, Jr., A. M. Dvorak, B. A. Barnes, E.J. Manseau, and S. J. 
Galli. 1979.  Rejection of first-set skin aliografts in man. The microvasculature is the 
critical target of the immune rsspgnse. J. Exp. Med. 150:322. 
11.  Bhan,  A.  K.,  M.  C.  Mihm, Jr, and H. F.  Dvorak.  1982.  T  cell subsets in allograft 
rejection. In situ characterization of T  cell subsets in human skin allografts by the 
use of monoclonal antibodies. J. Immunol.  129:1578. 
12.  de Wall,  R. M.  W.,  M. J. J. Bogman, C. N. Maass, L.  M.  H. Cornelissen,  W.J.M. 
Tax, and R. A. P.  Koene.  1983. Variable expression of Ia antigens on the vascular 
endothelium of mouse skin allografts. Nature (Lond.). 303:426. 
13.  Tyler, J. D., D. Steinmuller, S.J. Galli, and K. G. Waddick.  1983. Allospecific graft- 
versus-host lesions mediated in MHC-restricted fashion by cloned cytolytic T  lym- 
phocytes. Transplant. Proc. 15:1441. 
14.  Tyler, J.  D.,  and  D.  Steinmuller.  1982.  Establishment  of cytolytic T  lymphocyte 
clones to epidermal alloantigen Epa-1. Transplantation (Baltimore). 34:140. 
15.  Zagury, D., J.  Bernard,  N. Thierness,  M.  Feldman, and G. Berke.  1975.  Isolation 
and  characterization  of individual  functionally reactive  cytotoxic T  lymphocytes: 
conjugation killing and recycling at the single cell level. Eur. J. Immunol. 5:818. 
16.  Streilein, J. w.,  I. Zeiss, and D. Steinmuller.  1970. Studies on immune lymphocyte 
transfer reactions in  murine homologous cell chimeras.  Transplantation  (Baltimore). 
10:403. 
17.  Brooks, C. G., K. Kuribayashi, G. E. Sale, and C. S. Henney. 1982. Characterization 
of five cloned murine cell lines showing high cytolytic activity against YAC-1  cells.J. 
hnmunol.  128:2326. 
18.  Galli, S.J., A. M.  Dvorak, T. Ishizaka, G. Nabel, H. Der Simonian, H. Cantor, and 
H. F. Dvorak.  1982.  A cloned cell with NK function resembles basophils by ultra- 
structure and expresses IgE receptors. Nature (Lond.). 298:288. 
19.  Dvorak, A. M., A. J. Galli, J. A. Marcum, G. Nabel, H. Der Simonian, J. Goldin, R. 
A. Monahan, K. Pyne, H. Cantor, R. D. Rosenberg, and H. F. Dvorak. 1983. Cloned 
mouse  cells  wtih  natural  killer  function  and  cloned  suppressor  T  cells  express 
ultrastructural and biochemical features not shared by inducer T  cells. J. Exp. Med. 
157:513. 
20.  Hackett, C. J., K. Sullivan, and Y.-L. Lin.  1982. Ultrastructure of an influenza virus- TYLER ET  AL.  243 
specific cytotoxic T-cell clone and its interaction with P815 and macrophage targets. 
Cell Immunol.  68:276. 
21.  Crowle, A.J. 1975.  Delayed hypersensitivity in the mouse. Adv. Immunol.  20:197. 
22.  Palladino, M. A., A.  M.  Carroll, M.  De Sousa, S.  Giilis, M.  P.  Scheid, and H.  F. 
Oettgen. 1983.  Characterization of IL-2 dependent cytotoxic T-cell clones.  II. Cell- 
surface  phenotypes,  histochemical  and  ultrastructural  properties.  Cell Immunol. 
76:276. 
23.  Engers,  H.  D.,  A.  L.  Glasebrook, and G.  D.  Sorenson.  1982.  Allogeneic tumor 
rejection  induced by the  intravenous injection of Lyt-2  + cytolytic T  lymphocyte 
ciones.J. Exp. Med.  156:1280. 
24.  Widmer, M. B., and F. H. Bach. 1081. Antigen driven helper cell independent cloned 
cytolytic T  iymphocytes. Nature (Lond.). 294:750. 
25.  Prystowsky, M. B., J. M. Ely, D. I. Belier, L. Eisenberg, J. Goldman, M. Goldman, E. 
Goldwasser, J.  Ihle, J.  Quintans,  H.  Remold, S.  Vogel,  and  F.  W.  Fitch.  1982. 
Alioreactive cloned T cell lines. IV. Multiple lymphokine activities secreted by helper 
and cytolytic cloned T  lymphocytes.J. Immunol.  129:2337. 
26.  Galli, S.J., R. C. Bast, Jr, B. Bast, T. Isomura, B. Zbar, H.J. Rapp, and H. F. Dvorak. 
1982.  Bystander suppression of tumor growth: evidence that specific  targets and 
bystanders  are  damaged  by  injury  to  a  common  microvasculature. J.  lmmunol. 
129:1790. 
27.  Tilney, N. L., T. B. Strom, S. G. McPherson, and C. B. Carpenter.  1975.  Surface 
properties and functional characteristics of infiltrating cells harvested from acutely 
rejecting cardiac allografts in inbred rats. Transplantation  (Baltimore). 20:323. 
28.  Strom, T. B.,  N.  L. Tilney, C. B. Carpenter, and G. J. Busch.  1975.  Identity and 
cytotoxic capacity of cells infiltrating renal allografts. N. Engl. J. Med. 292:1257. 
29.  Strom, T. B., N. L. Tilney, J. M. Peradysz, J. Bacewicz, and C. B. Carpenter. 1977. 
Cellular components of allograft rejection. Identity specificity and cytotoxic function 
of cells infiltrating acutely rejecting allografts.J. Immunol.  118:2020. 
30.  von Willebrand, E., A. Soots, and P. H~iyry. 1979.  In situ effector mechanisms in rat 
kidney allograft rejection. Cell Immunol.  46:309. 
31.  Tilney, N.  L., J.  Notis-McConaty, and T.  B.  Strom.  1978.  Specificity  of cellular 
migration into cardiac allografts in rats. Transplantation  (Baltimore). 26:181. 
32.  Robert, T. J., and P. H/iyry. 1976.  Sponge matrix allografts; a model for analysis of 
killer cells infiltrating mouse allografts. Transplantation  (Baltimore). 21:437. 
33.  Canty, T. G., and J. P.  Wunderlich.  1971.  Quantitative assessment of cellular and 
humoral responses to skin and tumor allografts. Transplantation  (Baltimore). 11:111. 
34.  von Willebrand, E.,  and P.  Hfiyry. 1978.  Composition and in vitro cytotoxicity of 
cellular infiltrates in rejecting human kidney allografts. Cell Immunol.  41:358. 
35.  Benz, H.,  H. Wigzell,  and P.  Hfiyry. 1976.  Characteristics of allograft infiltrating 
cells: positive correlation between specific cytolytic  activity  and expression ofidiotypic 
receptors. Nature (Lond.). 259:401. 
36.  Loveland, B.  E.,  and  I.  F.  C.  McKenzie.  1982.  Delayed-type hypersensitivity and 
allograft rejection in the mouse: correlation of effector cell phenotype. Immunology. 
46:313. 
37.  Streilein, J.  W.,  and  P.  R.  Bergstresser.  1983.  Haptens  can  serve  as  surrogate 
transplantation antigens in a  manner  that demonstrates  H-2  restriction  of graft 
rejection.J. Exp. Med.  157:1354. 
38.  Kim, B.,  M.  Rosenstein, D.  Weiland, T. J.  Eberlein, and S.  A. Rosenberg.  1983. 
Clonal analysis of the lymphoid cells mediating skin allograft rejection; cloned Lyt- 
1÷,2  - proliferative, non-cytotoxic long-term cell lines mediate graft rejection in vivo. 
Transplantation  (Baltimore). 36:525. 